Stocks and Investing
Stocks and Investing
Thu, May 28, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, May 27, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jay Olson Maintained (ACAD) at Hold with Increased Target to $53 on, May 27th, 2020
Jay Olson of Oppenheimer, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $48 to $53 on, May 27th, 2020.
Jay has made no other calls on ACAD in the last 4 months.
There are 4 other peers that have a rating on ACAD. Out of the 4 peers that are also analyzing ACAD, 0 agree with Jay's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Jay
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $63 on, Friday, May 8th, 2020
- Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $60 on, Thursday, April 16th, 2020
- Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $72 on, Tuesday, March 31st, 2020
- Neena Bitritto-Garg of "Citigroup" Initiated at Strong Buy and Held Target at $69 on, Friday, March 6th, 2020